Medifast (MED) Non-Current Deferred Tax Liability (2010 - 2018)

Medifast has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at -$208000.0 in Q4 2018.

• For the quarter ending Q4 2018, Non-Current Deferred Tax Liability fell 200.0% year-over-year to -$208000.0; the trailing twelve-month figure through Dec 2018 stood at -$208000.0 (down 200.0% YoY), and the FY2018 full-year result was -$208000.0, down 200.0% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2018 stood at -$208000.0, down from $16000.0 in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $6.6 million in Q1 2014, with the low at -$208000.0 in Q4 2018.
• Historically, Non-Current Deferred Tax Liability has averaged $3.2 million across 5 years, with a median of $3.7 million in 2015.
• Annual changes were most pronounced in 2015 — Non-Current Deferred Tax Liability rose 7.61% — and 2018, when it sank 200.0%.
• Medifast's Non-Current Deferred Tax Liability stood at $5.5 million in 2014, then tumbled by 32.96% to $3.7 million in 2015, then tumbled by 78.84% to $779000.0 in 2016, then slumped by 73.3% to $208000.0 in 2017, then slumped by 200.0% to -$208000.0 in 2018.
• The last three Non-Current Deferred Tax Liability figures came in at -$208000.0 (Q4 2018), $16000.0 (Q1 2018), and $208000.0 (Q4 2017), per Business Quant data.